- •Preface
- •List of contributers
- •History, epidemiology, prevention and education
- •A history of burn care
- •“Black sheep in surgical wards”
- •Toxaemia, plasmarrhea, or infection?
- •The Guinea Pig Club
- •Burns and sulfa drugs at Pearl Harbor
- •Burn center concept
- •Shock and resuscitation
- •Wound care and infection
- •Burn surgery
- •Inhalation injury and pulmonary care
- •Nutrition and the “Universal Trauma Model”
- •Rehabilitation
- •Conclusions
- •References
- •Epidemiology and prevention of burns throughout the world
- •Introduction
- •Epidemiology
- •The inequitable distribution of burns
- •Cost by age
- •Cost by mechanism
- •Limitations of data
- •Risk factors
- •Socioeconomic factors
- •Race and ethnicity
- •Age-related factors: children
- •Age-related factors: the elderly
- •Regional factors
- •Gender-related factors
- •Intent
- •Comorbidity
- •Agents
- •Non-electric domestic appliances
- •War, mass casualties, and terrorism
- •Interventions
- •Smoke detectors
- •Residential sprinklers
- •Hot water temperature regulation
- •Lamps and stoves
- •Fireworks legislation
- •Fire-safe cigarettes
- •Children’s sleepwear
- •Acid assaults
- •Burn care systems
- •Role of the World Health Organization
- •Conclusions and recommendations
- •Surveillance
- •Smoke alarms
- •Gender inequality
- •Community surveys
- •Acknowledgements
- •References
- •Prevention of burn injuries
- •Introduction
- •Burns prevalence and relevance
- •Burn injury risk factors
- •WHERE?
- •Burn prevention types
- •Burn prevention: The basics to design a plan
- •Flame burns
- •Prevention of scald burns
- •Conclusions
- •References
- •Burns associated with wars and disasters
- •Introduction
- •Wartime burns
- •Epidemiology of burns sustained during combat operations
- •Fluid resuscitation and initial burn care in theater
- •Evacuation of thermally-injured combat casualties
- •Care of host-nation burn patients
- •Disaster-related burns
- •Epidemiology
- •Treatment of disaster-related burns
- •The American Burn Association (ABA) disaster management plan
- •Summary
- •References
- •Education in burns
- •Introduction
- •Surgical education
- •Background
- •Simulation
- •Education in the internet era
- •Rotations as courses
- •Mentorship
- •Peer mentorship
- •Hierarchical mentorship
- •What is a mentor
- •Implementation
- •Interprofessional education
- •What is interprofessional education
- •Approaches to interprofessional education
- •References
- •European practice guidelines for burn care: Minimum level of burn care provision in Europe
- •Foreword
- •Background
- •Introduction
- •Burn injury and burn care in general
- •Conclusion
- •References
- •Pre-hospital and initial management of burns
- •Introduction
- •Modern care
- •Early management
- •At the accident
- •At a local hospital – stabilization prior to transport to the Burn Center
- •Transportation
- •References
- •Medical documentation of burn injuries
- •Introduction
- •Medical documentation of burn injuries
- •Contents of an up-to-date burns registry
- •Shortcomings in existing documentation systems designs
- •Burn depth
- •Burn depth as a dynamic process
- •Non-clinical methods to classify burn depth
- •Burn extent
- •Basic principles of determining the burn extent
- •Methods to determine burn extent
- •Computer aided three-dimensional documentation systems
- •Methods used by BurnCase 3D
- •Creating a comparable international database
- •Results
- •Conclusion
- •Financing and accomplishment
- •References
- •Pathophysiology of burn injury
- •Introduction
- •Local changes
- •Burn depth
- •Burn size
- •Systemic changes
- •Hypovolemia and rapid edema formation
- •Altered cellular membranes and cellular edema
- •Mediators of burn injury
- •Hemodynamic consequences of acute burns
- •Hypermetabolic response to burn injury
- •Glucose metabolism
- •Myocardial dysfunction
- •Effects on the renal system
- •Effects on the gastrointestinal system
- •Effects on the immune system
- •Summary and conclusion
- •References
- •Anesthesia for patients with acute burn injuries
- •Introduction
- •Preoperative evaluation
- •Monitors
- •Pharmacology
- •Postoperative care
- •References
- •Diagnosis and management of inhalation injury
- •Introduction
- •Effects of inhaled gases
- •Carbon monoxide
- •Cyanide toxicity
- •Upper airway injury
- •Lower airway injury
- •Diagnosis
- •Resuscitation after inhalation injury
- •Other treatment issues
- •Prognosis
- •Conclusions
- •References
- •Respiratory management
- •Airway management
- •(a) Endotracheal intubation
- •(b) Elective tracheostomy
- •Chest escharotomy
- •Conventional mechanical ventilation
- •Introduction
- •Pathophysiological principles
- •Low tidal volume and limited plateau pressure approaches
- •Permissive hypercapnia
- •The open-lung approach
- •PEEP
- •Lung recruitment maneuvers
- •Unconventional mechanical ventilation strategies
- •High-frequency percussive ventilation (HFPV)
- •High-frequency oscillatory ventilation
- •Airway pressure release ventilation (APRV)
- •Ventilator associated pneumonia (VAP)
- •(a) Prevention
- •(b) Treatment
- •References
- •Organ responses and organ support
- •Introduction
- •Burn shock and resuscitation
- •Post-burn hypermetabolism
- •Individual organ systems
- •Central nervous system
- •Peripheral nervous system
- •Pulmonary
- •Cardiovascular
- •Renal
- •Gastrointestinal tract
- •Conclusion
- •References
- •Critical care of thermally injured patient
- •Introduction
- •Oxidative stress control strategies
- •Fluid and cardiovascular management beyond 24 hours
- •Other organ function/dysfunction and support
- •The nervous system
- •Respiratory system and inhalation injury
- •Renal failure and renal replacement therapy
- •Gastro-intestinal system
- •Glucose control
- •Endocrine changes
- •Stress response (Fig. 2)
- •Low T3 syndrome
- •Gonadal depression
- •Thermal regulation
- •Metabolic modulation
- •Propranolol
- •Oxandrolone
- •Recombinant human growth hormone
- •Insulin
- •Electrolyte disorders
- •Sodium
- •Chloride
- •Calcium, phosphate and magnesium
- •Calcium
- •Bone demineralization and osteoporosis
- •Micronutrients and antioxidants
- •Thrombosis prophylaxis
- •Conclusion
- •References
- •Treatment of infection in burns
- •Introduction
- •Clinical management strategies
- •Pathophysiology of the burn wound
- •Burn wound infection
- •Cellulitis
- •Impetigo
- •Catheter related infections
- •Urinary tract infection
- •Tracheobronchitis
- •Pneumonia
- •Sepsis in the burn patient
- •The microbiology of burn wound infection
- •Sources of organisms
- •Gram-positive organisms
- •Gram-negative organisms
- •Infection control
- •Pharmacological considerations in the treatment of burn infections
- •Topical antimicrobial treatment
- •Systemic antimicrobial treatment (Table 3)
- •Gram-positive bacterial infections
- •Enterococcal bacterial infections
- •Gram-negative bacterial infections
- •Treatment of yeast and fungal infections
- •The Polyenes (Amphotericin B)
- •Azole antifungals
- •Echinocandin antifungals
- •Nucleoside analog antifungal (Flucytosine)
- •Conclusion
- •References
- •Acute treatment of severely burned pediatric patients
- •Introduction
- •Initial management of the burned child
- •Fluid resuscitation
- •Sepsis
- •Inhalation injury
- •Burn wound excision
- •Burn wound coverage
- •Metabolic response and nutritional support
- •Modulation of the hormonal and endocrine response
- •Recombinant human growth hormone
- •Insulin-like growth factor
- •Oxandrolone
- •Propranolol
- •Glucose control
- •Insulin
- •Metformin
- •Novel therapeutic options
- •Long-term responses
- •Conclusion
- •References
- •Adult burn management
- •Introduction
- •Epidemiology and aetiology
- •Pathophysiology
- •Assessment of the burn wound
- •Depth of burn
- •Size of the burn
- •Initial management of the burn wound
- •First aid
- •Burn blisters
- •Escharotomy
- •General care of the adult burn patient
- •Biological/Semi biological dressings
- •Topical antimicrobials
- •Biological dressings
- •Other dressings
- •Exposure
- •Deep partial thickness wound
- •Total wound excision
- •Serial wound excision and conservative management
- •Full thickness burns
- •Excision and autografting
- •Topical antimicrobials
- •Large full thickness burns
- •Serial excision
- •Mixed depth burn
- •Donor sites
- •Techniques of wound excision
- •Blood loss
- •Antibiotics
- •Anatomical considerations
- •Skin replacement
- •Autograft
- •Allograft
- •Other skin replacements
- •Cultured skin substitutes
- •Skin graft take
- •Rehabilitation and outcome
- •Future care
- •References
- •Burns in older adults
- •Introduction
- •Burn injury epidemiology
- •Pathophysiologic changes and implications for burn therapy
- •Aging
- •Comorbidities
- •Acute management challenges
- •Fluid resuscitation
- •Burn excision
- •Pain and sedation
- •End of life decisions
- •Summary of key points and recommendations
- •References
- •Acute management of facial burns
- •Introduction
- •Anatomy and pathophysiology
- •Management
- •General approach
- •Airway management
- •Facial burn wound management
- •Initial wound care
- •Topical agents
- •Biological dressings
- •Surgical burn wound excision of the face
- •Wound closure
- •Special areas and adjacent of the face
- •Eyelids
- •Nose and ears
- •Lips
- •Scalp
- •The neck
- •Catastrophic injury
- •Post healing rehabilitation and scar management
- •Outcome and reconstruction
- •Summary
- •References
- •Hand burns
- •Introduction
- •Initial evaluation and history
- •Initial wound management
- •Escharotomy and fasciotomy
- •Surgical management: Early excision and grafting
- •Skin substitutes
- •Amputation
- •Hand therapy
- •Secondary reconstruction
- •References
- •Treatment of burns – established and novel technology
- •Introduction
- •Partial thickness burns
- •Biological membranes – amnion and others
- •Xenograft
- •Full thickness burns
- •Dermal analogs
- •Keratinocyte coverage
- •Facial transplantation
- •Tissue engineering and stem cells
- •Gene therapy and growth factors
- •Conclusion
- •References
- •Wound healing
- •History of wound care
- •Types of wounds
- •Mechanisms of wound healing
- •Hemostasis
- •Proliferation
- •Epithelialization
- •Remodeling
- •Fetal wound healing
- •Stem cells
- •Abnormal wound healing
- •Impaired wound healing
- •Hypertrophic scars and keloids
- •Chronic non-healing wounds
- •Conclusions
- •References
- •Pain management after burn trauma
- •Introduction
- •Pathophysiology of pain after burn injuries
- •Nociceptive pain
- •Neuropathic pain
- •Sympathetically Maintained Pain (SMP)
- •Pain rating and documentation
- •Pain management and analgesics
- •Pharmacokinetics in severe burns
- •Form of administration [21]
- •Non-opioids (Table 1)
- •Paracetamol
- •Metamizole
- •Non-steroidal antirheumatics (NSAID)
- •Selective cyclooxygenasis-2-inhibitors
- •Opioids (Table 2)
- •Weak opioids
- •Strong opioids
- •Other analgesics
- •Ketamine (see also intensive care unit and analgosedation)
- •Anticonvulsants (Gabapentin and Pregabalin)
- •Antidepressants with analgesic effects
- •Regional anesthesia
- •Pain management without analgesics
- •Adequate communication
- •Psychological techniques [65]
- •Transcutaneous electrical nerve stimulation (TENS)
- •Particularities of burn pain
- •Wound pain
- •Breakthrough pain
- •Intervention-induced pain
- •Necrosectomy and skin grafting
- •Dressing change of large burn wounds and removal of clamps in skin grafts
- •Dressing change in smaller burn wounds, baths and physical therapy
- •Postoperative pain
- •Mental aspects
- •Intensive care unit
- •Opioid-induced hyperalgesia and opioid tolerance
- •Hypermetabolism
- •Psychic stress factors
- •Risk of infection
- •Monitoring [92]
- •Sedation monitoring
- •Analgesia monitoring (see Fig. 2)
- •Analgosedation (Table 3)
- •Sedation
- •Analgesia
- •References
- •Nutrition support for the burn patient
- •Background
- •Case presentation
- •Patient selection: Timing and route of nutritional support
- •Determining nutritional demands
- •What is an appropriate initial nutrition plan for this patient?
- •Formulations for nutritional support
- •Monitoring nutrition support
- •Optimal monitoring of nutritional status
- •Problems and complications of nutritional support
- •Conclusion
- •References
- •HBO and burns
- •Historical development
- •Contraindications for the use of HBO
- •Conclusion
- •References
- •Nursing management of the burn-injured person
- •Introduction
- •Incidence
- •Prevention
- •Pathophysiology
- •Severity factors
- •Local damage
- •Fluid and electrolyte shifts
- •Cardiovascular, gastrointestinal and renal system manifestations
- •Types of burn injuries
- •Thermal
- •Chemical
- •Electrical
- •Smoke and inhalation injury
- •Clinical manifestations
- •Subjective symptoms
- •Possible complications
- •Clinical management
- •Non-surgical care
- •Surgical care
- •Coordination of care: Burn nursing’s unique role
- •Nursing interventions: Emergent phase
- •Nursing interventions: Acute phase
- •Nursing interventions: Rehabilitative phase
- •Ongoing care
- •Infection prevention and control
- •Rehabilitation medicine
- •Nutrition
- •Pharmacology
- •Conclusion
- •References
- •Outpatient burn care
- •Introduction
- •Epidemiology
- •Accident causes
- •Care structures
- •Indications for inpatient treatment
- •Patient age
- •Total burned body surface area (TBSA)
- •Depth of the burn
- •Pre-existing conditions
- •Accompanying injuries
- •Special injuries
- •Treatment
- •Initial treatment
- •Pain therapy
- •Local treatment
- •Course of treatment
- •Complications
- •Infections
- •Follow-up care
- •References
- •Non-thermal burns
- •Electrical injury
- •Introduction
- •Pathophysiology
- •Initial assessment and acute care
- •Wound care
- •Diagnosis
- •Low voltage injuries
- •Lightning injuries
- •Complications
- •References
- •Symptoms, diagnosis and treatment of chemical burns
- •Chemical burns
- •Decontamination
- •Affection of different organ systems
- •Respiratory tract
- •Gastrointestinal tract
- •Hematological signs
- •Nephrologic symptoms
- •Skin
- •Nitric acid
- •Sulfuric acid
- •Caustic soda
- •Phenol
- •Summary
- •References
- •Necrotizing and exfoliative diseases of the skin
- •Introduction
- •Necrotizing diseases of the skin
- •Cellulitis
- •Staphylococcal scalded skin syndrome
- •Autoimmune blistering diseases
- •Epidermolysis bullosa acquisita
- •Necrotizing fasciitis
- •Purpura fulminans
- •Exfoliative diseases of the skin
- •Stevens-Johnson syndrome
- •Toxic epidermal necrolysis
- •Conclusion
- •References
- •Frostbite
- •Mechanism
- •Risk factors
- •Causes
- •Diagnosis
- •Treatment
- •Rewarming
- •Surgery
- •Sympathectomy
- •Vasodilators
- •Escharotomy and fasciotomy
- •Prognosis
- •Research
- •References
- •Subject index
Review of geriatric burn care
these types of injuries are frequently under-reported [27]. Under-reporting of physical abuse and neglect occurs when the older adult is dependent on the abuser for care, feels shame or guilt from the event, or has impaired cognitive abilities. A British review of burns occurring in residential care facilities reported that inadequate staff supervision accounted for the majority of injuries, commonly from hot water scalds and contact with radiators [28]. In both types of injuries, residents with dementia and impaired mobility sustained burns because they were left unsupervised for variable periods of time. Appropriate recognition and management of non-acci- dental burns is challenging, as these injuries are associated with higher mortality rates when compared to accidental burns with similar characteristics [29, 30]. The recommended approach is to use a protocol for assessment, reporting and intervention in a multidisciplinary environment when elder abuse is suspected [31].
Pathophysiologic changes and implications for burn therapy
Aging
The aged skin is responsible for delayed wound healing in older adults. The dermis progressively thins with age, with a decrease in collagen content and extracellular matrix. The aging dermis has reduced microcirculation, macrophages and fibroblasts. In contrast, epidermal thickness is preserved with age, although there is flattening of the dermal-epidermal junction (rete ridges), making the epidermis more prone to shearing. Aging alters all phases of wound healing, from hemostasis and inflammation, to proliferation and resolution [32]. The rate of epidermal turnover is reduced by 50% after age 65, with fewer epidermal-lined skin appendages to permit re-epi- thelialization [33, 34]. Additionally, some environmental exposures can contribute to premature skin aging, such as tobacco smoking, sun exposure, and alcoholism-induced nutritional deficiencies [35]. Diabetes, chronic anticoagulation, and steroid immunosuppression are frequent comorbidities that predispose to premature skin aging and impaired wound healing. Clinically, burn providers often ob-
serve that even shallow-appearing partial thickness burn wounds in older adults can have significantly delayed re-epithelialization. In patients undergoing excision and grafting, delayed healing in donor sites and grafted wounds limits our ability to achieve early and complete wound closure.
Age-related changes in multiple organ systems contribute to the decreased physiologic reserve in older adults. Cardiac index decreases 1% per year whereas systemic vascular resistance rises 1% per year. Maximal heart rate and responses to adrenergic stimulation are also reduced with age [36]. Increased cardiovascular system stiffness (in the heart, arteries and arterioles) leads to an increased in pulse wave velocity and resetting of the baroreflex, thus causing the resting systolic pressure to rise. The aging cardiovascular system is more susceptible to the effects of hypovolemia, with a greater reduction in stroke volume and arterial systolic pressures. Respiratory performance decreases with age because of reduced chest wall compliance, decreased diaphragm strength, and alveolar airspace enlargement. Both forced vital capacity (FVC) and forced expiratory volume in 1 second (FEV1) decrease over time [37]. Progressive renal deterioration is marked by a decrease in kidney size after age 50, with morphological changes often accelerated in the setting of diabetes and hypertension. Functionally, the age-dependent reduction in glomerular filtration rate (GFR) renders aging kidneys susceptible to second physiologic insults during critical illness [38]. Cognitive performance declines with age, although the underlying mechanisms are not fully characterized. Recent research indicates that brain tissue atrophy with aging may be concentrated in the loss of white matter fibers, resulting in altered relationships between cortical regions. This phenomenon has been termed “cortical disconnection”, a deficit in integration between different networks [39, 40].
Aging also causes progressive loss of lean body mass, weakened muscle strength and reduced physical function [41]. Frailty itself is an important risk factor for injuries from falls, and poor hospitalization outcomes [42, 43]. Post-burn hyperdynamic and hypermetabolic responses are relatively blunted in older adults, although these patients still suffer from persistent catabolism, and loss of lean body mass[44, 45] Together, these factors constitute an enormous
281
T. N. Pham
barrier to physical recovery in older patients. Early provision of nutritional support, maintenance of warm ambient temperatures, and control of infection are important strategies to mitigate the catabolic state. Pharmacologic agents to modulate hypermetabolism in older adults may achieve a similar benefit to those demonstrated in children with severe burns [46–49]. Oxandrolone, a testosterone analog with weak virilizing potential, is a promising agent for it induces anabolism in both older men and women after only two weeks of therapy [50]. The non-selective beta-blocker propranolol reduces tachycardia, energy expenditure, substrate cycling, and prevents fatty acid infiltration of the liver in severely burned children, but its application has not yet been reported in older adults with burns [45, 48]. This strategy is particularly appealing since aged patients do not tolerate tachycardia well. However, be- ta-adrenergic blockade must be balanced against the risks of inducing bradycardia and hypotension. The benefits of exercise regimens for older patients are numerous, including improved general health, faster hospitalization recovery in multiple conditions, and reduced repeat injuries [51–53]. The combination of anabolic agent supplementation and exercise should be a core component of a comprehensive rehabilitation plan, but thus far remains to be validated in older adults with burns.
Important changes in the aged host immune responses may partially account for post-injury complications and a higher susceptibility to infections. Aging alters antigen presentation, cytokine production, phagocyte activity and chemotaxis in multiple innate immune cells [54, 55]. Senescence also affects cell-mediated immunity with atrophy of the thymus, reduced naïve T-cells, and decreased T-cell memory [56]. At baseline, healthy older adults exhibit a chronic inflammatory state, characterized by higher circulating levels of pro-inflammatory mediators (TNF- , IL-1, IL-6). This condition has been termed “inflamm-aging”, and presumably arises from repeated exposure to antigens and other sources of cell stress [57]. After injury, early organ dysfunction develops more frequently in older adults with burns. It typically begins with acute lung and kidney injury, followed by deterioration in multiple organ systems [58]. Recent findings in a mouse burn injury model provide a potential mechanistic explanation for a
higher incidence of pulmonary dysfunction in the aged host: burn-injured aged mice have protracted neutrophil infiltration and chemokine production in the lung compared younger mice [59]. Animal models of aging and sepsis demonstrate that the aged host immune response to infectious challenges is markedly altered. Aged mice respond poorly to either endotoxin challenge or cecal ligation and puncture (CLP) [60]. Turnbull et al. reported that aged mice have 70% mortality with CLP compared to 20% in young mice, and that antibiotic therapy initiated 12 hours after CLP does not significantly improve survival in older mice [61]. Although a burn + sepsis model in aged animals has not yet been reported, patient outcomes data give ample evidence that this combination is a strong risk factor for late-onset multiple organ dysfunction syndrome (MODS) and death [62, 63].
Comorbidities
The relationship between injury and comorbidity is synergistic. Conditions such as smoking, physical disability, and altered sensorium are clear predisposing factors to burn injury [64, 65]. Additionally, the incidence of pre-injury comorbidities may be as high as 85% and frequently complicates the care of older burn patients [6]. Co-morbidities comprise a heterogeneous set of conditions, each with a different impact on burn management. Chronic obstructive lung disease and smoking strongly predict the development of pulmonary complications in older adults with burns [66]. Cardiac dysfunction may alter the timing of surgical procedures and can delay liberation from mechanical ventilation. The optimization of patients with systolic and diastolic heart dysfunction, or rhythm abnormalities may require additional diagnostic tests and invasive monitoring [67]. In contrast, well-managed comorbidities prior to injury may actually constitute a survival advantage: Arbabi et al. reported that older burn patients taking a beta-blocker prior to injury had better survival than those not treated with beta-blocker [68]. Whether this results from a biological effect of betablocker or simply better pre-injury care remains to be clarified. At the opposite end of the spectrum, patients on oxygen therapy who continue to smoke may be difficult to wean from mechanical ventilation
282